Ysios closes €126m BioFundSpanish start-ups, take heed: One of the biggest biotech funds in Southern Europe has just been closed by Ysios Capital. The Spanish venture firm raised €126.4m to be reinvested in European biotech, … more ➔
Merck drops MS collaboration with ApitopeApitope said it has regained global rights to its IL-10-bolstering vaccination ATX-MS-1467 for remitting-relapsing multiple sclerosis from Merck KGaA. A 2009 contract forsaw that Merck will … more ➔
EPO rules threaten biotech industryThe European Patent Offices decision to speed up examination of patent applications to 12 months without any transition period is set to ruin biotech SMEs financially and may send a blocking signal … more ➔
Roches NSLC mAb outperforms chemoRoche is making up lost ground in immuno-oncology. The Swiss companys PD-L1 directed immunotherapy atezolizumab is more effective in combatting lung cancer than standard chemotherapy. more ➔
Synvina: BASF and Avantium join forcesThe new joint venture Synvina is positioned in the market for drop-in bioplastics with advanced product characteristics. more ➔
CPhI sheds light on future marketsWith about 38,000 attendees and 2,500 exhibitors, CPhI worldwide in Barcelona has broken another record. Personalised 3D printed pills and hypothesis generation using big data were only two trends … more ➔
EC delays bioeconomy strategy reviewThe fate of the bioeconomy in Europe remains undecided. The evaluation of the European Commissions bioeconomy strategy plus action plan has been delayed. more ➔
Apeiron licences neuroblastoma antibodyAustrian Apeiron Biologics has outlicensed the global marketing rights for its neuroblastoma antibody dinutuximab beta to British Eusa Pharma. more ➔
Diabetes giant cuts jobsDanish insulin maker Novo Nordisk tries to relieve financial pressure by laying off 1,000 staff. The step was necessary due to challenges on the US market, the company said. more ➔
Bluebird bio selects Medigene for TCR deve... CAR T cell specialist bluebird bio has inked a potential US$1bn partnership with Medigene – to get access to the drug developers technology platform. more ➔
